FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.

Alzheimer’s disease community computerized assessment early detection memory memory impairment new technologies patient engagement subjective memory complaints

Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
06 Jan 2024
Historique:
medline: 13 1 2024
pubmed: 13 1 2024
entrez: 13 1 2024
Statut: aheadofprint

Résumé

The FACEmemory® online platform comprises a complex memory test and sociodemographic, medical, and family questions. This is the first study of a completely self-administered memory test with voice recognition, pre-tested in a memory clinic, sensitive to Alzheimer's disease, using information and communication technologies, and offered freely worldwide. To investigate the demographic and clinical variables associated with the total FACEmemory score, and to identify distinct patterns of memory performance on FACEmemory. Data from the first 3,000 subjects who completed the FACEmemory test were analyzed. Descriptive analyses were applied to demographic, FACEmemory, and medical and family variables; t-test and chi-square analyses were used to compare participants with preserved versus impaired performance on FACEmemory (cut-off = 32); multiple linear regression was used to identify variables that modulate FACEmemory performance; and machine learning techniques were applied to identify different memory patterns. Participants had a mean age of 50.57 years and 13.65 years of schooling; 64.07% were women, and 82.10% reported memory complaints with worries. The group with impaired FACEmemory performance (20.40%) was older, had less schooling, and had a higher prevalence of hypertension, diabetes, dyslipidemia, and family history of neurodegenerative disease than the group with preserved performance. Age, schooling, sex, country, and completion of the medical and family history questionnaire were associated with the FACEmemory score. Finally, machine learning techniques identified four patterns of FACEmemory performance: normal, dysexecutive, storage, and completely impaired. FACEmemory is a promising tool for assessing memory in people with subjective memory complaints and for raising awareness about cognitive decline in the community.

Sections du résumé

BACKGROUND BACKGROUND
The FACEmemory® online platform comprises a complex memory test and sociodemographic, medical, and family questions. This is the first study of a completely self-administered memory test with voice recognition, pre-tested in a memory clinic, sensitive to Alzheimer's disease, using information and communication technologies, and offered freely worldwide.
OBJECTIVE OBJECTIVE
To investigate the demographic and clinical variables associated with the total FACEmemory score, and to identify distinct patterns of memory performance on FACEmemory.
METHODS METHODS
Data from the first 3,000 subjects who completed the FACEmemory test were analyzed. Descriptive analyses were applied to demographic, FACEmemory, and medical and family variables; t-test and chi-square analyses were used to compare participants with preserved versus impaired performance on FACEmemory (cut-off = 32); multiple linear regression was used to identify variables that modulate FACEmemory performance; and machine learning techniques were applied to identify different memory patterns.
RESULTS RESULTS
Participants had a mean age of 50.57 years and 13.65 years of schooling; 64.07% were women, and 82.10% reported memory complaints with worries. The group with impaired FACEmemory performance (20.40%) was older, had less schooling, and had a higher prevalence of hypertension, diabetes, dyslipidemia, and family history of neurodegenerative disease than the group with preserved performance. Age, schooling, sex, country, and completion of the medical and family history questionnaire were associated with the FACEmemory score. Finally, machine learning techniques identified four patterns of FACEmemory performance: normal, dysexecutive, storage, and completely impaired.
CONCLUSIONS CONCLUSIONS
FACEmemory is a promising tool for assessing memory in people with subjective memory complaints and for raising awareness about cognitive decline in the community.

Identifiants

pubmed: 38217602
pii: JAD230983
doi: 10.3233/JAD-230983
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Montserrat Alegret (M)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Spain.

Fernando García-Gutiérrez (F)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.

Nathalia Muñoz (N)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.

Ana Espinosa (A)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Spain.

Gemma Ortega (G)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Spain.

Núria Lleonart (N)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.

Isabel Rodríguez (I)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.

Maitee Rosende-Roca (M)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.

Vanesa Pytel (V)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.

Yahveth Cantero-Fortiz (Y)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.

Dorene M Rentz (DM)

Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Marta Marquié (M)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Spain.

Sergi Valero (S)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Spain.

Agustın Ruiz (A)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Spain.

Christopher Butler (C)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Department of Brain Sciences, Imperial College London, London, UK.

Mercè Boada (M)

Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Spain.

Classifications MeSH